Emerald Bioscience (EMBI) Short Interest Ratio & Short Volume → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free EMBI Stock Alerts $15.64 +1.30 (+9.07%) (As of 03/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartStock AnalysisChart Emerald Bioscience Short Interest DataCurrent Short Volume865,200 sharesPrevious Short Volume861,200 sharesChange Vs. Previous Month+0.46%Dollar Volume Sold Short$76,570.20Short Interest Ratio / Days to Cover0.2Last Record DateJanuary 15, 2021Outstanding Shares268,074,000 sharesPercentage of Shares Shorted0.32%Today's Trading Volume26,253 sharesAverage Trading Volume14,236,620 sharesToday's Volume Vs. Average0% Short Selling Emerald Bioscience ? Sign up to receive the latest short interest report for Emerald Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatEMBI Short Interest Over TimeEMBI Days to Cover Over TimeEMBI Percentage of Float Shorted Over Time Ad Vertical Research Advisory“The Stock Market’s Bull Run is Far from Over” -BarronsBarron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months!Click here for all the details now… Emerald Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/15/2021865,200 shares $76,570.20 +0.5%N/A0.2 $0.09 12/31/2020857,500 shares $34,300.00 -0.9%N/A0.1 $0.04 12/15/2020865,200 shares $28,551.60 +0.5%N/A0.2 $0.03 11/30/2020861,200 shares $26,783.32 +1.0%N/A0.5 $0.03 11/15/2020852,500 shares $31,116.25 -2.0%N/A2.9 $0.04 10/30/2020869,800 shares $34,531.06 -11.6%N/A2.9 $0.04 Get the Latest News and Ratings for EMBI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emerald Bioscience and its competitors with MarketBeat's FREE daily newsletter. 10/15/2020983,600 shares $38,360.40 +15.4%N/A1.7 $0.04 9/30/2020852,500 shares $36,146.00 No ChangeN/A1.2 $0.04 9/15/2020852,500 shares $35,208.25 -59.2%N/A0.7 $0.04 8/31/20202,090,400 shares $94,068.00 +5.4%N/A1.3 $0.05 8/14/20201,982,500 shares $99,125.00 +85.7%N/A0.5 $0.05 7/31/20201,067,800 shares $54,137.46 +0.9%N/A4.6 $0.05 7/15/20201,057,900 shares $132,131.71 -1.4%N/A5.2 $0.12 6/30/20201,072,800 shares $168,000.48 -0.5%N/A4 $0.16 6/15/20201,078,200 shares $123,993.00 +1.2%N/A2.3 $0.12 5/29/20201,065,700 shares $105,504.30 +0.8%N/A5 $0.10 5/15/20201,057,800 shares $89,807.22 -0.4%N/A7.2 $0.08 4/30/20201,061,800 shares $106,180.00 +0.4%N/A7.1 $0.10 4/15/20201,057,800 shares $74,680.68 -1.2%N/A10 $0.07 3/31/20201,070,100 shares $80,257.50 -0.9%N/A4.3 $0.08 3/13/20201,079,300 shares $97,137.00 -1.6%N/A4.6 $0.09 2/28/20201,096,300 shares $103,929.24 +6.9%N/A3.3 $0.09 2/14/20201,025,900 shares $100,435.61 -6.8%N/A1.6 $0.10 1/31/20201,101,100 shares $186,966.78 +24.2%N/A1.5 $0.17 1/15/2020886,400 shares $141,824.00 +1.1%N/A3.1 $0.16 12/31/2019876,700 shares $122,738.00 +1.1%N/A3.2 $0.14 EMBI Short Interest - Frequently Asked Questions What is Emerald Bioscience's current short interest? Short interest is the volume of Emerald Bioscience shares that have been sold short but have not yet been closed out or covered. As of January 15th, investors have sold 865,200 shares of EMBI short. Learn More on Emerald Bioscience's current short interest. Is Emerald Bioscience's short interest increasing or decreasing? Emerald Bioscience saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 865,200 shares, an increase of 0.5% from the previous total of 861,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emerald Bioscience's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Emerald Bioscience: SpringWorks Therapeutics, Inc. (15.14%), Prestige Consumer Healthcare Inc. (3.79%), Axsome Therapeutics, Inc. (15.41%), ImmunityBio, Inc. (40.37%), Fortrea Holdings Inc. (5.99%), Sotera Health (9.16%), CymaBay Therapeutics, Inc. (5.10%), GN Store Nord A/S (0.00%), Surgery Partners, Inc. (11.01%), Envista Holdings Co. (5.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($6.62 billion), Analog Devices, Inc. ($4.85 billion), Aon plc ($4.66 billion), DuPont de Nemours, Inc. ($3.84 billion), International Flavors & Fragrances Inc. ($3.60 billion), Moderna, Inc. ($3.22 billion), Snap Inc. ($3.21 billion), Snowflake Inc. ($2.82 billion), The Kroger Co. ($2.52 billion), and Peloton Interactive, Inc. ($2.51 billion). View all of the most shorted stocks. What does it mean to sell short Emerald Bioscience stock? Short selling EMBI is an investing strategy that aims to generate trading profit from Emerald Bioscience as its price is falling. EMBI shares are trading up $1.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emerald Bioscience? A short squeeze for Emerald Bioscience occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMBI, which in turn drives the price of the stock up even further. How often is Emerald Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMBI, twice per month. The most recent reporting period available is January, 15 2021. More Short Interest Resources from MarketBeat Related Companies: SpringWorks Therapeutics Short Interest Prestige Consumer Healthcare Short Interest Axsome Therapeutics Short Interest ImmunityBio Short Interest Fortrea Short Interest Sotera Health Short Interest CymaBay Therapeutics Short Interest GN Store Nord A/S Short Interest Surgery Partners Short Interest Envista Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMBI) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the Markets